We examined breathing mechanics and a,PI deficiency in 1,850 unrelated male subjects with various lung complaints.
In an attempt to solve this problem, 2,3 investigations were based upon two approaches: 1) determination of the prevalence of heterozygotes among patients with COPD, and 2) whether or not heterozygotic subjects had COPD more often than control subjects.
One of the main problems in comparing the results of the various reported studies has been the lack of consistency in criteria used to define COPD. For this reason, we decided to study a well-defined subgroup of the COPD population, namely: patients who suffered from a so-called "flaccid lung." The term flaccid lung pertains to a loss of elasticity of the lung parenchyma defined as a high compliance in relation to the actual functional residual capacity. 4 Individuals were considered to have a flaccid lung when the volume compliance is >1.0 kPa -1 compared to the volume compliance of normal lung elasticity which is between 0.5 and 0. 
SUBJECTS AND METHODS

Subjects
In the period 1979-1984, 1,850 unrelated male patients with COPD, visiting the outpatient lung department of St Antonius Hospital, Utrecht/Nieuwegein, The Netherlands, were examined for pulmonary function including breathing mechanics and blood gases both at rest and during exercise.
We have investigated 82 percent of the patients for several years, (mean observation time 7.4 years, range 1-27 years); 75 percent of them had had one or more clinical check-ups. The minimum observation time in all cases was one year.
The healthy control subjects were a random sample of Dutch blood donors. 5 The patients were then subdivided into groups, according to their volume compliance: 1) those with a normal or increased lung elasticity (internal controls), 2) those with a decreased lung elasticity (the flaccid lung group), and 3) an intermediate group of patients. The volume compliance, (the ratio of quasi-static lung compliance: functional residual capacity), was used as the discriminating factor. The patients, family, social and work history, smoking habits, chest x-ray film studies, lung function test results (including esophageal pressure-volume studies), and blood gas levels both at rest and during exercise were recorded.
Methods
Sera were stored in batches at -30°C immediately after collection. PI phenotyping was carried out using isoelectric focusing with restricted pH range carrier ampholytes, a separator, and a highly crosslinked gel. 6 The level of a,-PI was determined by single radial immunodiffusion. Aliquots of pooled sera from 326 healthy blood donors served as a reference standard to which a value of 100 percent was assigned. Spirograms were made using water-sealed spirographs. The functional residual capacity (FRC) was measured with the helium dilution method, using a 33 percent initial helium concentration in a 40 percent oxygen, 27 percent nitrogen mixture.
The coefficient of variation for repeated FRC measurements in norma! subjects was 4.2 percent.
Lung compliance (CL) was measured with a Latex balloon 10 cm in length. In each instance, a pressure-volume plot of the balloon was made in air to test the standard quality, and the inter-balloon comparability. 7 The balloon was placed in the esophagus under x-ray guidance with its lower tip 4 cm below the main bifurcation. A pressure-volume plot of the balloon in situ was made, and in line with this plot, the filling of the balloon was fixed at mid-plateau. In each patient, three quasi-static expiratory P-V curves were produced. The quasi-static lung compliance (CL) was calculated from the best fitting line going from FRC to FRC + 0.5 liter. Intra-patient comparability was good, though dependent on the correct positioning of body and head and the balloon. Standard error in 50 normal subjects was ±0.104 L/kPa. Airway resistance (R) was calculated from the viscous work (W) as derived from the surface area of a tidal pressure-volume loop (VT,I) according to the formula:
In each patient the measurements of CL, R and lung volumes including FRC were made before and after administration of a bronchodilator drug at the same session. The data given in the tables are those obtained after bronchodilation. The following lung function parameters were used in this study: the inspiratory vital capacity (VC, L, BTPS) as a percentage of the predicted vital capacity (VCP); the volumic or specific compliance as the quotient of lung compliance and the actual functional residual capacity (CV = CL/ FRC, kPa -1 ); 7 the ratio between the forced one second expiratory volume (FEV,) and the one second inspiratory volume (FIVJ; the residual volume (RV,L,BTPS) as a percentage of the total lung capacity (TLC).
Pronounced loss in lung elasticity is characterized by a significant decrease in FEV], whereas the FIV, stays normal, leading to a definite decrease in the FEVyFIV, ratio, normal range 0.75-0.85. Age, height and body weight, as well as the smoking habits at the last check-up were used. All data were coded and computerized for analysis using the statistical program package SPSS. 9 
RESULTS
In the total population studied, the following phenotypes were found (exact numbers are available at request): MM, MI, MF, MX, FF, FS, MS, SS, MZ, FZ, SZ, ZO, ZZ, MO and a rare PI type (SWFIN). 10 In order to be able to perform a reliable statistical analysis, the rare phenotypes were excluded and our study was focused on the remaining 1716 MM, MS, MZ and ZZ individuals. The demographic characteristics and lung parameters of the patients with flaccid lung are shown in Table 2 . A new and surprising finding is that the ZZ individuals are significantly taller than the MM individuals (p <0.05). Furthermore, both the FEV As the average a,-PI concentration in the different phenotype groups in the flaccid lung population did not differ significantly from that in either the internal controls or in that of the healthy control population, an acute phase reaction was not likely to be present among the patients studied. lung disease in a large number of individuals with PI MZ, it was concluded that the MZ phenotype alone carries no greater risk of developing lung disease than MM phenotype. 13 Other studies have shown a significantly higher number of MZ individuals among COPD patients as compared to control subjects. 1416 The risk of developing COPD for PI MZ individuals in these studies was on average three times higher than that of the normal population. These differing conclusions are due, in our opinion, to differences in the number of individuals studied and to the different criteria to define COPD. For instance, in contrast to the present study, most investigators did not measure compliance which is the only method of measuring lung elasticity.
We conclude that if a PI MZ individual does develop a flaccid lung, the excess risk due to the deficiency is negligible compared to MM individuals and is highly influenced or modified by other factors, possibly environmental (smoking, genetic). This is in agreement with the findings of one of the few investigators who did measure the compliance and concluded that the risk of disablement from chronic lung disease appears to be only slightly enhanced by intermediate ctjAT deficiency. 17 In view of the development of a reliable substitution therapy for a,-antitrypsin deficient individuals, 18 the early recognition of ZZ homozygotes will become more and more important in the future. For this reason we have started collecting and studying families of MZ and ZZ propositi. 18 
